Literature DB >> 11721765

Second opinion pathology in liver biopsy interpretation.

P A Bejarano1, A Koehler, K E Sherman.   

Abstract

OBJECTIVE: Clinical management of liver diseases is often based on the interpretation of the pathologist examining liver biopsies. Many pathologists have little formal training and experience with these tissues. The magnitude of this problem is not determined yet. The goal of this study was to determine the diagnostic discrepancies that surfaced after a second opinion by experienced hepatopathologists interpreting liver biopsy tissues.
METHODS: All 178 consecutive liver biopsy tissue glass slides provided to hepatology consultants in 1996 and 1997 were selected for evaluation. Specimens with neoplasms, transplant-related indications, or those specifically referred by a community-based pathologist for consultation were excluded. Diagnosis and interpretations were compared with the reports from the original institutions. Discordant interpretations were grouped in major (description or diagnosis that would change management decisions) and minor (not likely to alter management) categories. Monetary cost of the pathology studies was analyzed.
RESULTS: A total of 125 specimens corresponding to 124 patients met inclusion criteria. Thirty-five (28%) and 47 (37.6%) biopsies had major and minor discrepancies, respectively. Full agreement was obtained in 43 (34.4%) cases. Fifteen (42.8%) of the major interpretation errors were on patients with chronic cholestatic disorders, nine (25.7%) with hepatocellular processes, and 11 (31.4%) were related to establishing the presence or absence of cirrhosis. Reviewing the 125 liver biopsies of this study by the consultants resulted in a 46% increase in monetary cost.
CONCLUSIONS: Practitioners making clinical decisions based on liver biopsy interpretation need to be aware that in a significant number of cases, pathologists are not able to arrive at a correct diagnosis, and thus seeking second opinions on the patients' behalf from experienced pathologists on liver diseases would be prudent. General pathologists should become more familiar with the abnormalities involving interlobular bile ducts and the diagnostic value of certain ancillary histological stains. Clinicians should provide pathologists with sufficient clinical information in terms of laboratory evaluations and clinical findings, so that accurate diagnosis might be facilitated.

Entities:  

Mesh:

Year:  2001        PMID: 11721765     DOI: 10.1111/j.1572-0241.2001.05273.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  10 in total

Review 1.  Therapeutic approach to the treatment-naive patient with hepatitis C virus genotype 1 infection: a step-by-step approach.

Authors:  Kenneth E Sherman
Journal:  Clin Infect Dis       Date:  2012-07-26       Impact factor: 9.079

2.  Morphometric analysis of hepatic steatosis in chronic hepatitis C infection.

Authors:  Alia Zubair; Shahid Jamal; Azhar Mubarik
Journal:  Saudi J Gastroenterol       Date:  2009-01       Impact factor: 2.485

Review 3.  Chronic hepatitis C and liver fibrosis.

Authors:  Giada Sebastiani; Konstantinos Gkouvatsos; Kostas Pantopoulos
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

4.  Checkmate to liver biopsy in chronic hepatitis C?

Authors:  Anca Trifan; Carol Stanciu
Journal:  World J Gastroenterol       Date:  2012-10-21       Impact factor: 5.742

5.  Accuracy of routine clinical ultrasound for staging of liver fibrosis.

Authors:  Chih-Ching Choong; Sudhakar K Venkatesh; Edwin P Y Siew
Journal:  J Clin Imaging Sci       Date:  2012-09-25

Review 6.  Liver biopsy for histological assessment: The case against.

Authors:  Faisal M Sanai; Emmet B Keeffe
Journal:  Saudi J Gastroenterol       Date:  2010 Apr-Jun       Impact factor: 2.485

7.  Impact of neuroradiologist second opinion on staging and management of head and neck cancer.

Authors:  John T Lysack; Monica Hoy; Mark E Hudon; Steven C Nakoneshny; Shamir P Chandarana; T Wayne Matthews; Joseph C Dort
Journal:  J Otolaryngol Head Neck Surg       Date:  2013-06-05

8.  Inter-observer and Intra-observer Agreement in Pathological Evaluation of Non-alcoholic Fatty Liver Disease Suspected Liver Biopsies.

Authors:  Omid Pournik; Seyed Moayed Alavian; Leila Ghalichi; Bahram Seifizarei; Leila Mehrnoush; Azam Aslani; Soghra Anjarani; Saeid Eslami
Journal:  Hepat Mon       Date:  2014-01-03       Impact factor: 0.660

9.  Guidelines on the use of liver biopsy in clinical practice from the British Society of Gastroenterology, the Royal College of Radiologists and the Royal College of Pathology.

Authors:  James Neuberger; Jai Patel; Helen Caldwell; Susan Davies; Vanessa Hebditch; Coral Hollywood; Stefan Hubscher; Salil Karkhanis; Will Lester; Nicholas Roslund; Rebecca West; Judith I Wyatt; Mathis Heydtmann
Journal:  Gut       Date:  2020-05-28       Impact factor: 23.059

10.  Inter-observer Variability in Histomorphological Evaluation of Non-neoplastic Liver Biopsy Tissue and Impact of Clinical Information on Final Diagnosis in Shahid Beheshti University of Medical Sciences Affiliated Hospitals.

Authors:  Zeinab Kishanifarahani; Mahsa Ahadi; Behrang Kazeminejad; Tahmineh Mollasharifi; Malihe Saber Afsharian; Amir Sadeghi; Farahnaz Bidari; Elena Jamali; Niki Hasanzadeh; Abolfazl Movafagh; Arash Dehghan; Arsham Moradi; Afshin Moradi
Journal:  Iran J Pathol       Date:  2019-08-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.